$0.730000
0.034.43%
At close: -
$0.723100
-0.0069-0.95%
After Hours: Nov 22, 7:26 PM EDT
Comments
Loading...
Cyclo Therapeutics (CYTH) Forecast
NewsEarningsCyclo Therapeutics (CYTH) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCyclo Therapeutics (NASDAQ:CYTH) Stock Quotes, Forecast and News Summary
Cyclo Therapeutics Stock (NASDAQ: CYTH) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cyclo Therapeutics (CYTH) stock?
You can purchase shares of Cyclo Therapeutics (NASDAQ:CYTH) through any online brokerage.
Who are Cyclo Therapeutics (CYTH) competitors?
Other companies in Cyclo Therapeutics’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT), Palatin Techs (AMEX:PTN) and GlycoMimetics (NASDAQ:GLYC).
What is the forecast, or price target, for Cyclo Therapeutics (CYTH) stock?
Cyclo Therapeutics has a consensus price target of $0.95.
What is the current price for Cyclo Therapeutics (CYTH)?
The stock price for Cyclo Therapeutics (NASDAQ: CYTH) is $0.7231 last updated November 22, 2024 at 7:26 PM EST.
Does Cyclo Therapeutics (CYTH) pay a dividend?
There are no upcoming dividends for Cyclo Therapeutics.
When is Cyclo Therapeutics (NASDAQ:CYTH) reporting earnings?
Cyclo Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Cyclo Therapeutics (CYTH) going to split?
There is no upcoming split for Cyclo Therapeutics.
What sector and industry does Cyclo Therapeutics (CYTH) operate in?
Cyclo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.